End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.54 CNY | +6.36% | -9.85% | -33.19% |
04-26 | Shaanxi Kanghui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-15 | Kanghui Pharmaceutical to Earn 151 Million Yuan from Kelavi Buyback | MT |
1st Jan change | Capi. | |
---|---|---|
-33.19% | 163M | |
+19.64% | 42.33B | |
+21.25% | 22.47B | |
+18.92% | 15.25B | |
+53.19% | 12.6B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.47B | |
+6.91% | 4.78B |
- Stock Market
- Equities
- 603139 Stock
- News Shaanxi Kanghui Pharmaceutical Co., Ltd.
- Hubei Klavi Biopharmaceutical Co., Ltd. announced that it has received CNY 50.4 million in funding from Shaanxi Kanghui Pharmaceutical Co., Ltd. and other investors